• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • R. López-Arnau, J. Martínez-Clemente, D. Pubill, E. Escubedo, J. Camarasa
  • Chemistry, Medicine
  • British journal of pharmacology
  • 2012 (First Publication: 1 September 2012)
  • BACKGROUND AND PURPOSE Here, we have compared the neurochemical profile of three new cathinones, butylone, mephedrone and methylone, in terms of their potential to inhibit plasmalemmal and vesicularExpand
  • D. Pubill, A. Canudas, M. Pallàs, A. Camins, J. Camarasa, E. Escubedo
  • Chemistry, Medicine
  • Naunyn-Schmiedeberg's Archives of Pharmacology
  • 2003 (First Publication: 1 May 2003)
  • The consequences of the neurotoxic insult induced by 3,4-methylenedioxymethamphetamine (MDMA, an amphetamine derivative with specific action on the serotonergic system) were compared with those ofExpand
  • R. López-Arnau, J. Martínez-Clemente, M. Carbó, D. Pubill, J. Camarasa
  • Psychology, Medicine
  • Progress in Neuro-Psychopharmacology and…
  • 2013 (First Publication: 1 August 2013)
  • INTRODUCTION Methylone (3,4-methylenedioxymethcathinone) is a new psychoactive substance and an active ingredient of "legal highs" or "bath salts". We studied the pharmacokinetics and locomotorExpand
  • E. Escubedo, C. Chipana, M. Pérez-Sánchez, J. Camarasa, D. Pubill
  • Medicine, Chemistry
  • Journal of Pharmacology and Experimental…
  • 2005 (First Publication: 1 November 2005)
  • In a previous study, we demonstrated that in rat striatal synaptosomes, methamphetamine (METH)-induced reactive oxygen species (ROS) production was prevented by methyllycaconitine (MLA), a specificExpand
  • R. López-Arnau, J. Martínez-Clemente, T. Rodrigo, D. Pubill, J. Camarasa, E. Escubedo
  • Medicine, Chemistry
  • Toxicology and applied pharmacology
  • 2015 (First Publication: 1 July 2015)
  • Mephedrone is a new designer drug of abuse. We have investigated the neurochemical/enzymatic changes after mephedrone administration to adolescent rats (3×25 mg/kg, s.c. in a day, with a 2 h intervalExpand